VANCOUVER, BC / ACCESSWIRE / / Arras Minerals Corp. (TSXV:ARK) (OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") ...
Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, INS1201.